|
1
|
Cen Z, Guo Y, Kong Q, Zhou Q and Wu W:
IL-10-producing B cells involved in the pathogenesis of Coxsackie
virus B3-induced acute viral myocarditis. Int J Clin Exp Pathol.
8:830–835. 2015.PubMed/NCBI
|
|
2
|
Yu Y, Yu Y, Liu M, Yu P, Liu G, Liu Y, Su
Y, Jiang H and Chen R: Ethyl pyruvate attenuated coxsackievirus
B3-induced acute viral myocarditis by suppression of
HMGB1/RAGE/NF-KB pathway. Springerplus. 5:2152016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu T, Chen J, Fan L, Xie W, Xu C and Wang
H: Effects of Shenqi Fuzheng injection on Fas/FasL protein
expression levels in the cardiomyocytes of a mouse model of viral
myocarditis. Exp Ther Med. 11:1839–1846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Willemsen RT, Buntinx F, Winkens B, Glatz
JF and Dinant GJ: 'RAPIDA'-study team: The value of signs, symptoms
and plasma heart-type fatty acid-binding protein (H-FABP) in
evaluating patients presenting with symptoms possibly matching
acute coronary syndrome: Background and methods of a diagnostic
study in primary care. BMC Fam Pract. 15:2032014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao Y, Hao L, Han CH and Zhang PY:
Protective effects of Wusen Erlian granules in experimental model
of viral myocarditis. Cell Biochem Biophys. 71:1129–1133. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li XQ, Liu XX, Wang XY, Xie YH, Yang Q,
Liu XX, Ding YY, Cao W and Wang SW: Cinnamaldehyde derivatives
inhibit coxsackievirus B3-induced viral myocarditis. Biomol Ther
(Seoul). 25:279–287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai Z, Shen L, Ma H, Yang J, Yang D, Chen
H, Wei J, Lu Q, Wang DW, Xiang M, et al: Involvement of endoplasmic
reticulum stress-mediated C/EBP homologous protein activation in
coxsackievirus B3-induced acute viral myocarditis. Circ Heart Fail.
8:809–818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sisakian HS, Asatryan BA and Nahapetyan
HM: Dilated cardiomyopathy: Evolution of pathogenesis concepts and
potential for new therapies. N Armen Med J. 9:4–18. 2015.
|
|
9
|
Yang F, Mo WH, Tan BP, Wei XM and Wang H:
Increased frequency of follicular helper T cells in mice viral
myocarditis is relevant with anti-ANT antoantibody. Virol J.
12:202015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu L, An XJ, Tian J and Wang Y: 124 cases
of clinical analysis of children with viral myocarditis. Eur Rev
Med Pharmacol Sci. 19:2856–2859. 2015.PubMed/NCBI
|
|
11
|
Zhu W, Lu Q, Wan L, Feng J and Chen HW:
Sodium tanshinone II A sulfonate ameliorates microcirculatory
disturbance of small intestine by attenuating the production of
reactie oxygen species in rats with sepsis. Chin J Integr Med.
22:745–751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsioufis K, Andrikopoulos G and Manolis A:
Trimetazidine and cardioprotection: Facts and perspectives.
Angiology. 66:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fernandes S, Salta S, Bravo J, Silva AP
and Summavielle T: Acetyl-L-carnitine prevents
methamphetamine-induced structural damage on endothelial cells via
ILK-related MMP-9 activity. Mol Neurobiol. 53:408–422. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glatz JF and Renneberg R: Added value of
H-FABP as plasma biomarker for the early evaluation of suspected
acute coronary syndrome. Clin Lipidol. 9:205–220. 2014. View Article : Google Scholar
|
|
15
|
Banning A, Musumeci F, Penny W and Tovey
JA: Reference intervals for cardiac troponin T, creatine kinase and
creatine kinase-MB isoenzyme following coronary bypass graft
surgery. Ann Clin Biochem. 33:561–562. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sandoval Y, Smith SW, Schulz KM, Murakami
MM, Love SA, Nicholson J and Apple FS: Diagnosis of type 1 and type
2 myocardial infarction using a high-sensitivity cardiac troponin I
assay with sex-specific 99th percentiles based on the third
universal definition of myocardial infarction classification
system. Clin Chem. 61:657–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murdaca G, Spanò F, Contatore M, Guastalla
A, Penza E, Magnani O and Puppo F: Infection risk associated with
anti-TNF-α agents: A review. Expert Opin Drug Saf. 14:571–582.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tokmadzić VS, Tsuji Y, Bogović T, Laskarin
G, Cupurdija K, Strbo N, Koyama K, Okamura H, Podack ER and
Rukavina D: IL-18 is present at the maternal-fetal interface and
enhances cytotoxic activity of decidual lymphocytes. Am J Reprod
Immunol. 48:191–200. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi J, Leung PSC, Bowlus C and Gershwin
ME: IL-35 and autoimmunity: A comprehensive perspective. Clin Rev
Allergy Immunol. 49:327–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wong CK, Leung TF, Chu IM, Dong J, Lam YY
and Lam CW: Aberrant expression of regulatory cytokine IL-35 and
pattern recognition receptor NOD2 in patients with allergic asthma.
Inflammation. 38:348–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
